These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14453834)

  • 1. Fibrinolysis. VII. Clot lysis, coagulation, and fibrinolytic mechanisms after administration of aspergillin O (mold fibrinolysin) in man.
    KARACA M; STEFANINI M; MELE R
    J Lab Clin Med; 1962 May; 59():799-814. PubMed ID: 14453834
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolysis. V. The thrombolytic and anticoagulant activity of mold fibrinolysin (Aspergillin O) in vivo.
    MARIN HM; STEFANINI M; SOARDI F; MUELLER L
    J Lab Clin Med; 1961 Jul; 58():47-59. PubMed ID: 13766766
    [No Abstract]   [Full Text] [Related]  

  • 3. CURRENT APPRAISAL OF THROMBOLYTIC THERAPY. A CRITICAL REVIEW.
    LIEBERMAN J
    Calif Med; 1963 Nov; 99(5):301-7. PubMed ID: 14081772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis. IX. The comparative activity in vivo of trypsin and aspergillin O (moldfibrinolysin).
    STEFANINI M; MARIN HM; SOARDI F; MOSSA A
    Angiology; 1962 Jun; 13():254-9. PubMed ID: 13916518
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinolysis. III. Nutritional and environmental requirements for optimum production of fibrinolysin from Aspergillus (aspergillin O).
    HORACE J; STEFANINI M
    Proc Soc Exp Biol Med; 1959 Oct; 102():201-3. PubMed ID: 14403065
    [No Abstract]   [Full Text] [Related]  

  • 6. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

  • 7. Global assays of fibrinolysis.
    Ilich A; Bokarev I; Key NS
    Int J Lab Hematol; 2017 Oct; 39(5):441-447. PubMed ID: 28497494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ON THE MECHANISM OF ACTION OF FIBRINOLYTIC SUBSTANCES].
    ROSOLLECK H
    Thromb Diath Haemorrh; 1963 Jul; 143():459-71. PubMed ID: 14081267
    [No Abstract]   [Full Text] [Related]  

  • 9. FIBRINOLYSIS IN RELATION TO THROMBOSIS.
    FLUTE PT
    Ann R Coll Surg Engl; 1965 Apr; 36(4):225-34. PubMed ID: 14280974
    [No Abstract]   [Full Text] [Related]  

  • 10. THROMBOANGIITIS OBLITERANS: WITH SPECIAL REFERENCE TO COAGULATION AND CLOT LYSIS.
    ENDE N
    Vasc Dis; 1964 Mar; 1():83-8. PubMed ID: 14186546
    [No Abstract]   [Full Text] [Related]  

  • 11. Coagulation, clot lysis, and thrombosis. I. Acid-labile inhibitor of fibrinolysis in rats fed thrombogenic diets.
    Sisson JA; Lee KT; Jadick PF; Thomas WA
    Exp Mol Pathol; 1968 Apr; 8(2):159-70. PubMed ID: 4231027
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct microscopic monitoring of initial and dynamic clot lysis using plasmin or rt-PA in an in vitro flow system.
    Bizjak N; Bajd F; Vidmar J; Blinc A; Perme MP; Marder VJ; Novokhatny V; Serša I
    Thromb Res; 2014 May; 133(5):908-13. PubMed ID: 24613694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood coagulation and fibrinolysis].
    Kienast J; Ostermann H
    Z Kardiol; 1993; 82 Suppl 2():65-9. PubMed ID: 8328211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasma.
    Leurs J; Wissing BM; Nerme V; Schatteman K; Björquist P; Hendriks D
    Thromb Haemost; 2003 Feb; 89(2):264-71. PubMed ID: 12574805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravascular fibrinolysis of small-vessel thrombosis.
    Cooney WP; Wilson MR; Wood MB
    J Hand Surg Am; 1983 Mar; 8(2):131-8. PubMed ID: 6220052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysin for thrombosis.
    Lancet; 1961 Apr; 1(7180):754-5. PubMed ID: 14447822
    [No Abstract]   [Full Text] [Related]  

  • 17. Concepts of clot lysis.
    Francis CW; Marder VJ
    Annu Rev Med; 1986; 37():187-204. PubMed ID: 2939790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma carboxypeptidase U (CPU, CPB2, TAFIa) generation during in vitro clot lysis and its interplay between coagulation and fibrinolysis.
    Leenaerts D; Aernouts J; Van Der Veken P; Sim Y; Lambeir AM; Hendriks D
    Thromb Haemost; 2017 Jul; 117(8):1498-1508. PubMed ID: 28692110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation of inhibitors of fibrinolysis to thrombolytic therapy.
    NORMAN PS
    Am Pract Dig Treat; 1962 Aug; 13():515-20. PubMed ID: 14480355
    [No Abstract]   [Full Text] [Related]  

  • 20. FIBRIN SUSPENSION ASSAY FOR FIBRINOLYTIC ACTIVITY.
    DYER AE; KADAR D
    Blood; 1964 Jun; 23():729-40. PubMed ID: 14161407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.